| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/22/1998 | EP0836621A1 Novel human g-protein coupled receptor |
| 04/22/1998 | EP0836613A1 Water-soluble adenosine kinase inhibitors |
| 04/22/1998 | EP0836606A1 Condensed thiazole derivatives, having 5-ht receptor affinity |
| 04/22/1998 | EP0836605A1 Pyrrolopyrimidines and processes for the preparation thereof |
| 04/22/1998 | EP0836592A1 Azepanes and their ring homologues for therapy and prophylaxis of protein kinase mediated diseases |
| 04/22/1998 | EP0836485A2 Cascade polymer complexes |
| 04/22/1998 | EP0836477A1 Antibacterial synergistic composition comprising rifabutin |
| 04/22/1998 | EP0836474A1 Method of altering the contents of eggs |
| 04/22/1998 | EP0836445A1 Method for regulating metabolism with dopamine beta hydroxylase inhibitors |
| 04/22/1998 | EP0836383A1 Combinations of inhibitors of farnesyl-protein transferase |
| 04/22/1998 | EP0836380A1 Fgf9 as a specific ligand for fgfr3 |
| 04/22/1998 | EP0764027A4 Method for protection against genotoxic mutagenesis |
| 04/22/1998 | EP0741686B1 New leukotriene b4 derivatives, methods of preparing them and their use as drugs |
| 04/22/1998 | EP0708755B1 Novel vitamin d analogues |
| 04/22/1998 | EP0697871A4 Treatment process with biologically active tropane derivatives |
| 04/22/1998 | EP0536275B1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 04/22/1998 | CN1179774A Arginine analogues having nitric oxide synthase inhibitor activity |
| 04/22/1998 | CN1179725A Modulation of cell proliferation and wound healing |
| 04/22/1998 | CN1179722A Combination therapy for HIV infection using HIV protease inhibitor indinavir and reverse transcriptase inhibitor 3TC, optionally together with AZT, DDI or DDC |
| 04/22/1998 | CN1179422A New flavone compounds, process for preparing them and pharmaceutical compositions containing them |
| 04/22/1998 | CN1179418A Novel cyloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 04/22/1998 | CN1179324A Specific pure herbal medicine narcotic oral liquid |
| 04/21/1998 | US5741912 Diagnosis, therapy |
| 04/21/1998 | US5741910 Compounds which are selective antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools |
| 04/21/1998 | US5741821 Use of natural products and related synthetic compounds for the treatment of cardiovascular disease |
| 04/21/1998 | US5741815 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 04/21/1998 | US5741809 Compounds and methods for the treatment of cardiovascular inflammatory and immune disorders |
| 04/21/1998 | US5741801 Ketone compounds with aromatic groups and amino groups |
| 04/21/1998 | US5741796 Pyridyl and naphthyridyl compounds for inhibiting osteoclast-mediated bone resorption |
| 04/21/1998 | US5741794 Platelet activating factor |
| 04/21/1998 | US5741790 Tachykinin antagonist and intermediates for nervous system disorders, antiinflammatory agents, antiarthritic agents, antidepressants and gastrointestinal disorders |
| 04/21/1998 | US5741781 Mercaptoalkanoyldipeptide compounds |
| 04/21/1998 | US5741778 Preventing neuronal cell death |
| 04/21/1998 | US5741670 Polypeptides |
| 04/21/1998 | US5741642 Assay for detecting the expression of a gene encoding human keratinocyte growth factor (KGF) |
| 04/21/1998 | US5741503 Method for regulating metabolism with dopamine beta hydroxylase inhibitors |
| 04/21/1998 | US5741486 Safe vectors for gene therapy |
| 04/21/1998 | CA2143301C N-(hydroxyethyl)butanediamide derivatives as renin inhibitors |
| 04/21/1998 | CA2143300C Renin inhibiting n-(2-amino-2-oxoethyl)butanediamide derivatives |
| 04/21/1998 | CA2087004C Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases |
| 04/16/1998 | WO1998015624A1 Galectin 8, 9, 10 and 10sv |
| 04/16/1998 | WO1998015575A1 Promoter for smooth muscle cell expression |
| 04/16/1998 | WO1998015563A1 Tetraphosphonate bicyclic trisanhydrides |
| 04/16/1998 | WO1998015556A1 TRICYCLIC COMPOUNDS HAVING ACTIVITY AS Ras-FPT INHIBITORS |
| 04/16/1998 | WO1998015545A1 New serotonin 5-ht1f agonists |
| 04/16/1998 | WO1998015543A1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same |
| 04/16/1998 | WO1998015294A1 Mononuclear phagocytes in therapeutic drug delivery |
| 04/16/1998 | WO1998015281A1 Induction of a cellular stress response with heavy metal salts |
| 04/16/1998 | WO1998015279A1 Hormonal composition consisting of an oestrogen compound and of a progestational compound |
| 04/16/1998 | WO1998015272A1 Method for inhibiting stress-activated protein kinases |
| 04/16/1998 | WO1998015267A1 Method for the treatment of neurological or neuropsychiatric disorders |
| 04/16/1998 | WO1998015266A1 Use of bisphenolic compounds to treat type ii diabetes |
| 04/16/1998 | WO1998015196A1 Compositions for postgastrectomic mineral supply |
| 04/16/1998 | DE19642591A1 Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung New piperidine-ketocarboxylic acid derivatives, their preparation and application |
| 04/16/1998 | DE19642451A1 Aminothiophencarbonsäureamide Aminothiophencarbonsäureamide |
| 04/16/1998 | DE19640791A1 Glycokonjugate als Inhibitoren der viralen Zelladhäsion Glycoconjugates as inhibitors of viral cell adhesion |
| 04/16/1998 | CA2268874A1 Use of bisphenolic compounds to treat type ii diabetes |
| 04/16/1998 | CA2268417A1 Mononuclear phagocytes in therapeutic drug delivery |
| 04/16/1998 | CA2268247A1 Induction of a cellular stress response with heavy metal salts |
| 04/16/1998 | CA2268164A1 New serotonin 5-ht1f agonists |
| 04/16/1998 | CA2268022A1 Galectin 8, 9, 10 and 10sv |
| 04/16/1998 | CA2267967A1 Method for inhibiting stress-activated protein kinases |
| 04/16/1998 | CA2267381A1 Method for the treatment of neurological or neuropsychiatric disorders |
| 04/16/1998 | CA2267154A1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same |
| 04/16/1998 | CA2267067A1 Promoter for smooth muscle cell expression |
| 04/15/1998 | EP0835937A2 Human MYT-1 kinase clone |
| 04/15/1998 | EP0835936A2 Arginyl tRNA synthase |
| 04/15/1998 | EP0835878A1 Benzo (b) thiophene compounds, intermediates, formulations, and methods |
| 04/15/1998 | EP0835872A1 Benzo [b] thiophene compounds, intermediates, formulations, and methods |
| 04/15/1998 | EP0835871A1 Benzo [b] thiophene compounds, intermediates, formulations, and methods |
| 04/15/1998 | EP0835869A2 New serotonin 5-HT1F agonists |
| 04/15/1998 | EP0835868A1 2-Aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods |
| 04/15/1998 | EP0835867A1 1-Aryloxy-2-arylnaphthyl compounds, intermediates, compositions, and methods |
| 04/15/1998 | EP0835656A1 Combination drug containing tramadol and a calcium channel antagonist |
| 04/15/1998 | EP0835447A1 Novel peptides and compositions which modulate apoptosis |
| 04/15/1998 | EP0835312A2 Recombinant mistletoe lectin |
| 04/15/1998 | EP0835264A1 Human g-protein receptor hcegh45 |
| 04/15/1998 | EP0835263A2 Somatostatin peptides |
| 04/15/1998 | EP0835262A1 Method for the treatment of corticosteroid induced osteopenia |
| 04/15/1998 | EP0835258A1 Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues |
| 04/15/1998 | EP0835253A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 04/15/1998 | EP0835246A1 Aromatic compounds and pharmaceutical compositions containing them |
| 04/15/1998 | EP0835128A1 Use of il-11 to treat inflammation |
| 04/15/1998 | EP0835115A1 4-(2-(n-2-carboxamidoindole)aminoethyl)-benzenesulfonamides or sulfonylureas as pdgf antagonists |
| 04/15/1998 | EP0835111A2 Method of dynamic retardation of cell cycle kinetics to potentiate cell damage |
| 04/15/1998 | EP0835109A1 Pyridinone-thrombin inhibitors |
| 04/15/1998 | EP0835108A1 Use of lamellarin-class alkaloids in methods of treatment |
| 04/15/1998 | EP0835107A1 The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence |
| 04/15/1998 | EP0699204B1 Use of indolocarbazole derivatives to treat a pathological condition of the prostate |
| 04/15/1998 | CN1179162A Heterocycle-fused thiazole derivatives |
| 04/15/1998 | CN1179156A Indole derivatives as 5 -HT receptor antagonist |
| 04/15/1998 | CN1179106A Recombinant human alpha-fetoprotein and uses thereof |
| 04/15/1998 | CN1179103A Prilocaine and hydrofluorocarbon aerosol preparations |
| 04/15/1998 | CN1038035C Preparing method for polyethylene protein conjugates |
| 04/14/1998 | US5739351 Neurokinin a antagonists |
| 04/14/1998 | US5739338 Skin disorders, antiinflammatory agents, antitumor agents, vision defects, viricides, immunosuppressants |
| 04/14/1998 | US5739322 Process for preparing BIS-indolyl macrocycles |
| 04/14/1998 | US5739308 Forms a duplex with a target nucleic acid and then form triplex with duplex formed between oligonucleotide and target ncleic acid |
| 04/14/1998 | US5739300 Antiadhesive piperidine-and pyrrolidinecarboxylic acids |
| 04/14/1998 | US5739164 Block metabotropic glutamate receptors |